Analyst Price Targets — OKYO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 29, 2026 11:52 am | Yi Chen | H.C. Wainwright | $7.00 | $1.96 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO) |
Latest News for OKYO
OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week announced the appointment of Dr. Marta Sacchetti to its scientific advisory board as the company advances development of its lead ophthalmic candidate targeting neuropathic corneal pain.
OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week announced the appointment of Dr. Marta Sacchetti to its scientific advisory board as the company advances...
OKYO Pharma (OKYO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
FTSE 100 up 11 points at 10,335 UK jobs data weakens, unemployment back to 5% IG Group, Diploma, Currys, Dr Martens, SSP, Cranswick among reporters ...
OKYO Pharma Ltd (NASDAQ:OKYO) announced that it has expanded its Scientific Advisory Board with the appointment of Dr. Marta Sacchetti as the company continues advancing its clinical programs in neuropathic corneal pain and inflammatory eye diseases.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OKYO.
U.S. House Trading
No House trades found for OKYO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.